Skip to main content
. 2014 Sep 5;40(3):611–626. doi: 10.1007/s12639-014-0546-z

Fig. 3.

Fig. 3

The survival time of different Me49 infected subgroups. (Ia) normal non infected control subgroup. (Ie) Avirulent Me49 infected control subgroup. (IIa2) CTLVECNS vaccinated subgroup challenged with avirulent Me49 strain. (IIb2) CTLV + FIA vaccinated subgroup challenged with avirulent Me49 strain